The Burden of Polypharmacy in Patients Near the End of Life

Journal of Pain and Symptom Management

Volumn 51, Issue 2, 2016, Pages 178-183.e2

  McNeil, Michael J ^a,c   Kamal, Arif H ^a,b,c   Kutner, Jean S ^d   Ritchie, Christine S ^e   Abernethy, Amy P ^a,b,c  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

end of life; Palliative care; polypharmacy

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMORBIDITY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NEOPLASMS; PALLIATIVE THERAPY; POLYPHARMACY; PROCEDURES; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TERMINAL CARE;

AGED; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; NEOPLASMS; PALLIATIVE CARE; POLYPHARMACY; PROSPECTIVE STUDIES; TERMINAL CARE;

EID: 84955724010     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2015.09.003     Document Type: Article

References (23)

1. D.C. Currow, J.P. Stevenson, A.P. Abernethy, J. Plummer, and T.M. Shelby-James Prescribing in palliative care as death approaches J Am Geriatr Soc 55 2007 590 595
2. K. Mamun, C.T. Lien, C.Y. Goh-Tan, and W.S. Ang Polypharmacy and inappropriate medication use in Singapore nursing homes Ann Acad Med Singapore 33 2004 49 52
3. F. Nauck, C. Ostgathe, E. Klaschik, and et al. Drugs in palliative care: results from a representative survey in Germany Palliat Med 18 2004 100 107
4. A. Wilcock, J. Thomas, J. Frisby, and et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit Br J Clin Pharmacol 60 2005 326 329
5. G. Zeppetella How do terminally ill patients at home take their medication? Palliat Med 13 1999 469 475
6. R.M. Goldberg, J. Mabee, L. Chan, and S. Wong Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population Am J Emerg Med 14 1996 447 450
7. K.E. Steinhauser, N.A. Christakis, E.C. Clipp, and et al. Factors considered important at the end of life by patients, family, physicians, and other care providers JAMA 284 2000 2476 2482
8. M.C. Weng, C.F. Tsai, K.L. Sheu, and et al. The impact of number of drugs prescribed on the risk of potentially inappropriate medication among outpatient older adults with chronic diseases QJM 106 2013 1009 1015
9. A.S. Kelley, K. McGarry, S. Fahle, and et al. Out-of-pocket spending in the last five years of life J Gen Intern Med 28 2013 304 309
10. A.P. Abernethy, J. K, and P.J. Blatchford Managing comorbidities in oncology: a multisite randomized controlled trial of continuing versus discontinuing statins in the setting of life-limiting illness [abstract] J Clin Oncol 32 Suppl 5 2014 abstr LBA9514
11. J.S. Kutner, P.J. Blatchford, D.H. Taylor, and et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial JAMA Intern Med 175 2015 691 700
12. A.P. Abernethy, N.M. Aziz, E. Basch, and et al. A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group J Palliat Med 13 2010 1407 1413
13. T.W. Leblanc, J.S. Kutner, D. Ko, and et al. Developing the evidence base for palliative care: formation of the palliative care research cooperative and its first trial Hosp Pract 38 2010 137 143
14. World Health Organization Guidelines for ATC classification and DDD assignment 2013 World Health Organization Geneva
15. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383
16. R.E. Ferner, and J.K. Aronson Communicating information about drug safety BMJ 333 2006 143 145
17. G. Onder, M. Petrovic, B. Tangiisuran, and et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score Arch Intern Med 170 2010 1142 1148
18. A. Kotlinska-Lemieszek, O. Paulsen, S. Kaasa, and P. Klepstad Polypharmacy in patients with advanced cancer and pain: a European cross-sectional study of 2282 patients J Pain Symptom Manage 48 2014 1145 1159
19. L. Sera, M.L. McPherson, and H.M. Holmes Commonly prescribed medications in a population of hospice patients Am J Hosp Palliat Care 31 2014 126 131
20. D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, and A.A. Mitchell Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 2002 337 344
21. D.M. Qato, G.C. Alexander, R.M. Conti, and et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 2008 2867 2878
22. H.M. Holmes Rational prescribing for patients with a reduced life expectancy Clin Pharmacol Ther 85 2009 103 107
23. J. Stevenson, A.P. Abernethy, C. Miller, and D.C. Currow Managing comorbidities in patients at the end of life BMJ 329 2004 909 912